Related Experiment Video
Updated: Jul 5, 2025

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
The regulatory mechanisms of oncomiRs in cancer
Khalid Otmani1, Redouane Rouas1, Mimoune Berehab1
1Hematology Laboratory, Hematology Department, Hôpital Universitaire de Bruxelles (H.U.B.) Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Abstract:
Cancer development is a complex process that primarily results from the combination of genetic alterations and the dysregulation of major signalling pathways due to interference with the epigenetic machinery. As major epigenetic regulators, miRNAs are central players in the control of many key tumour development factors. These miRNAs have been classified as oncogenic miRNAs (oncomiRs) when they target tumour suppressor genes and tumour suppressor miRNAs (TS miRNAs) when they inhibit oncogene protein expression. Most of the mechanisms that modulate oncomiR expression are linked to transcriptional or posttranscriptional regulation. However, non-transcriptional processes, such as gene amplification, have been described as alternative processes that are responsible for increasing oncomiR expression. The current review summarises the different mechanisms controlling the upregulation of oncomiR expression in cancer cells and the tumour microenvironment (TME). Detailed knowledge of the mechanism underlying the regulation of oncomiR expression in cancer may pave the way for understanding the critical role of oncomiRs in cancer development and progression.
Insights
This review explores how oncogenic microRNAs (oncomiRs) are upregulated in cancer. Understanding these epigenetic mechanisms is key to targeting oncomiRs for cancer therapy.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Research
Background:
- Cancer arises from genetic alterations and epigenetic dysregulation affecting signaling pathways.
- MicroRNAs (miRNAs) are key epigenetic regulators influencing tumor development.
- miRNAs are classified as oncogenic (oncomiRs) or tumor suppressive (TS miRNAs) based on their targets.
Purpose of the Study:
- To summarize mechanisms controlling the upregulation of oncomiRs in cancer cells and the tumor microenvironment (TME).
- To highlight the role of non-transcriptional processes, like gene amplification, in oncomiR overexpression.
- To provide insights into the critical role of oncomiRs in cancer development and progression.
Main Methods:
- Review of existing literature on miRNA regulation in cancer.
- Analysis of transcriptional, post-transcriptional, and non-transcriptional mechanisms.
- Focus on oncomiR expression control in cancer cells and the TME.
Main Results:
- OncomiR upregulation is driven by various regulatory mechanisms.
- Transcriptional and post-transcriptional modifications are common, but non-transcriptional processes like gene amplification also contribute.
- These mechanisms are active in both cancer cells and the surrounding tumor microenvironment.
Conclusions:
- Detailed understanding of oncomiR upregulation mechanisms is crucial for cancer research.
- Elucidating these pathways can reveal the critical role of oncomiRs in tumorigenesis.
- This knowledge may facilitate the development of novel cancer therapeutic strategies targeting oncomiRs.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
MicroRNAs
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Epigenetic Regulation
X-chromosome...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

